Search Results - "Pérez‐Moreno, Ana M."

Clovibactin: Discovery and antimicrobial mechanism of action by Pérez‐Moreno, Ana M., Torres, Pablo, Paris, Juan L.

Get full text

Influence of Pore Size in Protein G'‐Grafted Mesoporous Silica Nanoparticles as a Serum Pretreatment System for In Vitro Allergy Diagnosis by Paris, Juan L., Monío, Cristina, Pérez‐Moreno, Ana M., Jurado‐Escobar, Raquel, Bogas, Gador, Fernández, Tahía D., Montañez, María I., Mayorga, Cristobalina, Torres, María J.

“…Particles with the capacity to bind to immunoglobulin G (IgG) can be used for the purification of IgG or to process clinical samples for diagnostic purposes…”
Get full text

Correction: Immunomodulatory potential of rapamycin-loaded mesoporous silica nanoparticles: pore size-dependent drug loading, release, and in vitro cellular responses by Pérez-Moreno, Ana M., Aranda, Carlos J., Torres, María José, Mayorga, Cristobalina, Paris, Juan L.

Get full text

Immunomodulatory potential of rapamycin-loaded mesoporous silica nanoparticles: pore size-dependent drug loading, release, and in vitro cellular responses by Pérez-Moreno, Ana M., Aranda, Carlos J., Torres, María José, Mayorga, Cristobalina, Paris, Juan L.

“…Rapamycin is a potent immunosuppressive drug that has been recently proposed for a wide range of applications beyond its current clinical use. For some of…”
Get full text

Fatigue as a Predictor of Outcome in Patients With Heart Failure by Perez-Moreno, Ana Cristina, MD, Jhund, Pardeep S., MB ChB, PhD, Macdonald, Michael R., MD, Petrie, Mark C., MB, ChB, BSc, Cleland, John G.F., MD, Böhm, Michael, MD, PhD, van Veldhuisen, Dirk J., MD, PhD, Gullestad, Lars, MD, PhD, Wikstrand, John, MD, PhD, Kjekshus, John, MD, PhD, Lewsey, James D., PhD, McMurray, John J.V., MD

“…Objectives The purpose of this study was to examine the relationship between fatigue and clinical outcomes, using dyspnea as a comparator, in patients with…”
Get full text